Number Of Cardiovascular Risk Factors Could Determine Safety Of Intravenous Gammaglobulin Treatment

Thursday, March 5, 2009 - 09:49 in Health & Medicine

New research identifies the presence of cardiovascular risk factors as an indicator of how likely it is that elderly, hospitalized patients who receive intravenous immunoglobulin treatment will have a stroke or heart attack.

Read the whole article on Science Daily

More from Science Daily

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net